Structure

Physi-Chem Properties

Molecular Weight:  722.48
Volume:  796.424
LogP:  11.879
LogD:  4.443
LogS:  -6.207
# Rotatable Bonds:  33
TPSA:  111.52
# H-Bond Aceptor:  8
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.045
Synthetic Accessibility Score:  2.742
Fsp3:  0.591
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.369
MDCK Permeability:  8.603349670011085e-06
Pgp-inhibitor:  0.988
Pgp-substrate:  0.809
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.003
Plasma Protein Binding (PPB):  104.3158187866211%
Volume Distribution (VD):  5.719
Pgp-substrate:  0.5409589409828186%

ADMET: Metabolism

CYP1A2-inhibitor:  0.054
CYP1A2-substrate:  0.155
CYP2C19-inhibitor:  0.179
CYP2C19-substrate:  0.055
CYP2C9-inhibitor:  0.047
CYP2C9-substrate:  0.994
CYP2D6-inhibitor:  0.14
CYP2D6-substrate:  0.871
CYP3A4-inhibitor:  0.198
CYP3A4-substrate:  0.071

ADMET: Excretion

Clearance (CL):  5.636
Half-life (T1/2):  0.193

ADMET: Toxicity

hERG Blockers:  0.93
Human Hepatotoxicity (H-HT):  0.022
Drug-inuced Liver Injury (DILI):  0.227
AMES Toxicity:  0.022
Rat Oral Acute Toxicity:  0.025
Maximum Recommended Daily Dose:  0.387
Skin Sensitization:  0.993
Carcinogencity:  0.035
Eye Corrosion:  0.003
Eye Irritation:  0.552
Respiratory Toxicity:  0.421

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC83062

Natural Product ID:  NPC83062
Common Name*:   1,24-Tetracosanediol Diferulate
IUPAC Name:   24-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxytetracosyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
Synonyms:   1,24-Tetracosanediol Diferulate
Standard InCHIKey:  JVYGWGTXGGTEAZ-WWQQVGJXSA-N
Standard InCHI:  InChI=1S/C44H66O8/c1-49-41-35-37(25-29-39(41)45)27-31-43(47)51-33-23-21-19-17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-18-20-22-24-34-52-44(48)32-28-38-26-30-40(46)42(36-38)50-2/h25-32,35-36,45-46H,3-24,33-34H2,1-2H3/b31-27+,32-28+
SMILES:  COc1cc(/C=C/C(=O)OCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)/C=C/c2ccc(c(c2)OC)O)ccc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL443415
PubChem CID:   11967021
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0000059] Coumaric acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18781 Hyoscyamus niger Species Solanaceae Eukaryota seeds n.a. n.a. PMID[11858758]
NPO18781 Hyoscyamus niger Species Solanaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO18781 Hyoscyamus niger Species Solanaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18781 Hyoscyamus niger Species Solanaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO18781 Hyoscyamus niger Species Solanaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO18781 Hyoscyamus niger Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT858 Cell Line LNCaP Homo sapiens IC50 > 100000.0 nM PMID[546490]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC83062 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9754 High Similarity NPC213552
0.9754 High Similarity NPC120225
0.9672 High Similarity NPC289459
0.959 High Similarity NPC60517
0.959 High Similarity NPC146886
0.959 High Similarity NPC20443
0.959 High Similarity NPC246704
0.9308 High Similarity NPC120852
0.9302 High Similarity NPC135127
0.9286 High Similarity NPC110313
0.9262 High Similarity NPC204466
0.9242 High Similarity NPC106055
0.9242 High Similarity NPC110699
0.9225 High Similarity NPC475468
0.9187 High Similarity NPC70752
0.918 High Similarity NPC202474
0.9134 High Similarity NPC478215
0.9106 High Similarity NPC14007
0.9106 High Similarity NPC470848
0.9106 High Similarity NPC269843
0.9106 High Similarity NPC60962
0.9106 High Similarity NPC224814
0.9106 High Similarity NPC470849
0.9106 High Similarity NPC109083
0.9106 High Similarity NPC189844
0.9098 High Similarity NPC263386
0.9098 High Similarity NPC141791
0.9048 High Similarity NPC87113
0.9024 High Similarity NPC2058
0.9016 High Similarity NPC137537
0.9016 High Similarity NPC107588
0.9016 High Similarity NPC70744
0.9016 High Similarity NPC272471
0.9016 High Similarity NPC277460
0.9016 High Similarity NPC164706
0.9016 High Similarity NPC275519
0.9016 High Similarity NPC203124
0.9015 High Similarity NPC90431
0.9008 High Similarity NPC471110
0.8955 High Similarity NPC288452
0.8955 High Similarity NPC289690
0.8947 High Similarity NPC126206
0.8915 High Similarity NPC241354
0.8906 High Similarity NPC123722
0.8906 High Similarity NPC276466
0.8906 High Similarity NPC5018
0.8906 High Similarity NPC151167
0.8906 High Similarity NPC123228
0.8905 High Similarity NPC274960
0.8905 High Similarity NPC143120
0.8905 High Similarity NPC473909
0.8898 High Similarity NPC280767
0.8889 High Similarity NPC18984
0.8889 High Similarity NPC160900
0.8889 High Similarity NPC106659
0.8889 High Similarity NPC229084
0.8881 High Similarity NPC76032
0.8881 High Similarity NPC284409
0.8881 High Similarity NPC132723
0.888 High Similarity NPC147654
0.8872 High Similarity NPC471664
0.8872 High Similarity NPC471665
0.8862 High Similarity NPC470626
0.8862 High Similarity NPC309434
0.8828 High Similarity NPC179777
0.8828 High Similarity NPC84076
0.8828 High Similarity NPC303680
0.8828 High Similarity NPC90128
0.8824 High Similarity NPC140502
0.8824 High Similarity NPC67467
0.88 High Similarity NPC207613
0.879 High Similarity NPC37858
0.878 High Similarity NPC293619
0.878 High Similarity NPC280001
0.8769 High Similarity NPC304622
0.8768 High Similarity NPC252292
0.8768 High Similarity NPC34927
0.8768 High Similarity NPC100998
0.8768 High Similarity NPC34587
0.8768 High Similarity NPC476382
0.874 High Similarity NPC31344
0.874 High Similarity NPC317769
0.8731 High Similarity NPC471988
0.873 High Similarity NPC324571
0.873 High Similarity NPC54872
0.873 High Similarity NPC470212
0.873 High Similarity NPC312675
0.873 High Similarity NPC473853
0.873 High Similarity NPC262156
0.873 High Similarity NPC113865
0.873 High Similarity NPC184651
0.873 High Similarity NPC343720
0.8722 High Similarity NPC300776
0.8722 High Similarity NPC119060
0.8722 High Similarity NPC111635
0.8722 High Similarity NPC67247
0.8722 High Similarity NPC249791
0.8722 High Similarity NPC237594
0.8722 High Similarity NPC5310
0.8722 High Similarity NPC4982
0.8722 High Similarity NPC176814
0.8722 High Similarity NPC476387
0.8722 High Similarity NPC68779
0.872 High Similarity NPC95614
0.872 High Similarity NPC56214
0.872 High Similarity NPC242885
0.872 High Similarity NPC227217
0.872 High Similarity NPC117780
0.872 High Similarity NPC165133
0.872 High Similarity NPC232316
0.8714 High Similarity NPC102934
0.8714 High Similarity NPC252402
0.8699 High Similarity NPC281277
0.8692 High Similarity NPC109275
0.8689 High Similarity NPC261453
0.8689 High Similarity NPC33749
0.8689 High Similarity NPC294941
0.8689 High Similarity NPC328593
0.8682 High Similarity NPC276014
0.8682 High Similarity NPC118584
0.8672 High Similarity NPC273686
0.8672 High Similarity NPC312404
0.8667 High Similarity NPC281780
0.8661 High Similarity NPC85488
0.8661 High Similarity NPC286573
0.8657 High Similarity NPC113295
0.8657 High Similarity NPC477301
0.8652 High Similarity NPC94871
0.8652 High Similarity NPC470933
0.8652 High Similarity NPC471062
0.8652 High Similarity NPC473427
0.8652 High Similarity NPC475250
0.8652 High Similarity NPC259347
0.8652 High Similarity NPC306890
0.8652 High Similarity NPC476398
0.8652 High Similarity NPC476386
0.8643 High Similarity NPC232992
0.864 High Similarity NPC70084
0.864 High Similarity NPC281298
0.864 High Similarity NPC310338
0.8633 High Similarity NPC271607
0.8633 High Similarity NPC307205
0.8633 High Similarity NPC83743
0.8633 High Similarity NPC53884
0.8633 High Similarity NPC19862
0.8633 High Similarity NPC287615
0.8633 High Similarity NPC216819
0.8633 High Similarity NPC235195
0.8633 High Similarity NPC262182
0.8633 High Similarity NPC280717
0.8633 High Similarity NPC258671
0.8629 High Similarity NPC610
0.8629 High Similarity NPC39793
0.8629 High Similarity NPC200988
0.8629 High Similarity NPC145023
0.8629 High Similarity NPC86947
0.8629 High Similarity NPC175799
0.8626 High Similarity NPC48315
0.8623 High Similarity NPC478239
0.8618 High Similarity NPC233669
0.8618 High Similarity NPC474967
0.8607 High Similarity NPC95381
0.8605 High Similarity NPC194519
0.8605 High Similarity NPC257589
0.8605 High Similarity NPC67951
0.8605 High Similarity NPC53305
0.8594 High Similarity NPC257976
0.8594 High Similarity NPC471693
0.8594 High Similarity NPC242372
0.8594 High Similarity NPC4181
0.8594 High Similarity NPC164778
0.8594 High Similarity NPC280704
0.8593 High Similarity NPC471719
0.8593 High Similarity NPC157554
0.8592 High Similarity NPC257970
0.8592 High Similarity NPC470934
0.8592 High Similarity NPC188393
0.8592 High Similarity NPC470927
0.8583 High Similarity NPC127389
0.8583 High Similarity NPC38996
0.8583 High Similarity NPC160380
0.8583 High Similarity NPC290451
0.8583 High Similarity NPC177291
0.8583 High Similarity NPC194416
0.8582 High Similarity NPC473054
0.8571 High Similarity NPC245120
0.8561 High Similarity NPC304956
0.8561 High Similarity NPC160378
0.8561 High Similarity NPC110063
0.856 High Similarity NPC86198
0.856 High Similarity NPC124916
0.8551 High Similarity NPC157816
0.855 High Similarity NPC226661
0.854 High Similarity NPC267291
0.8538 High Similarity NPC178284
0.8538 High Similarity NPC92207
0.8538 High Similarity NPC191037
0.8538 High Similarity NPC127937
0.8538 High Similarity NPC58607
0.8537 High Similarity NPC217472

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC83062 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8889 High Similarity NPD4379 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD228 Approved
0.8333 Intermediate Similarity NPD5536 Phase 2
0.8333 Intermediate Similarity NPD7266 Discontinued
0.8209 Intermediate Similarity NPD3027 Phase 3
0.8162 Intermediate Similarity NPD4060 Phase 1
0.816 Intermediate Similarity NPD5283 Phase 1
0.8115 Intermediate Similarity NPD1358 Approved
0.7941 Intermediate Similarity NPD7095 Approved
0.7937 Intermediate Similarity NPD7843 Approved
0.7926 Intermediate Similarity NPD9494 Approved
0.7902 Intermediate Similarity NPD8166 Discontinued
0.7886 Intermediate Similarity NPD3134 Approved
0.7862 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD3022 Approved
0.784 Intermediate Similarity NPD3021 Approved
0.7803 Intermediate Similarity NPD3496 Discontinued
0.777 Intermediate Similarity NPD1653 Approved
0.7752 Intermediate Similarity NPD7157 Approved
0.7727 Intermediate Similarity NPD4626 Approved
0.7724 Intermediate Similarity NPD6190 Approved
0.7714 Intermediate Similarity NPD6355 Discontinued
0.7656 Intermediate Similarity NPD5535 Approved
0.7655 Intermediate Similarity NPD4110 Phase 3
0.7655 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7655 Intermediate Similarity NPD4628 Phase 3
0.7652 Intermediate Similarity NPD5691 Approved
0.7652 Intermediate Similarity NPD1357 Approved
0.7647 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD3620 Phase 2
0.7643 Intermediate Similarity NPD1613 Approved
0.7643 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7626 Intermediate Similarity NPD6798 Discontinued
0.7622 Intermediate Similarity NPD2935 Discontinued
0.7619 Intermediate Similarity NPD2684 Approved
0.7609 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD3455 Phase 2
0.7589 Intermediate Similarity NPD4340 Discontinued
0.7571 Intermediate Similarity NPD6233 Phase 2
0.7571 Intermediate Similarity NPD4062 Phase 3
0.7537 Intermediate Similarity NPD3847 Discontinued
0.7536 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD3882 Suspended
0.7518 Intermediate Similarity NPD1558 Phase 1
0.75 Intermediate Similarity NPD2982 Phase 2
0.75 Intermediate Similarity NPD2983 Phase 2
0.7482 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7481 Intermediate Similarity NPD3705 Approved
0.7469 Intermediate Similarity NPD7685 Pre-registration
0.7468 Intermediate Similarity NPD3817 Phase 2
0.7465 Intermediate Similarity NPD447 Suspended
0.7465 Intermediate Similarity NPD230 Phase 1
0.7452 Intermediate Similarity NPD8127 Discontinued
0.7451 Intermediate Similarity NPD1934 Approved
0.7447 Intermediate Similarity NPD2674 Phase 3
0.7444 Intermediate Similarity NPD1894 Discontinued
0.7436 Intermediate Similarity NPD6234 Discontinued
0.7426 Intermediate Similarity NPD2981 Phase 2
0.7413 Intermediate Similarity NPD6653 Approved
0.741 Intermediate Similarity NPD3018 Phase 2
0.7403 Intermediate Similarity NPD2801 Approved
0.7394 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7388 Intermediate Similarity NPD5585 Approved
0.7386 Intermediate Similarity NPD6386 Approved
0.7386 Intermediate Similarity NPD6385 Approved
0.7376 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD7097 Phase 1
0.7357 Intermediate Similarity NPD6832 Phase 2
0.7353 Intermediate Similarity NPD422 Phase 1
0.7353 Intermediate Similarity NPD1535 Discovery
0.7351 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD6671 Approved
0.7347 Intermediate Similarity NPD3060 Approved
0.7338 Intermediate Similarity NPD6584 Phase 3
0.7329 Intermediate Similarity NPD5763 Approved
0.7329 Intermediate Similarity NPD5762 Approved
0.7323 Intermediate Similarity NPD968 Approved
0.7319 Intermediate Similarity NPD1283 Approved
0.7299 Intermediate Similarity NPD1481 Phase 2
0.729 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD7054 Approved
0.7273 Intermediate Similarity NPD4140 Approved
0.7267 Intermediate Similarity NPD4357 Discontinued
0.7266 Intermediate Similarity NPD2797 Approved
0.7262 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD7075 Discontinued
0.726 Intermediate Similarity NPD6032 Approved
0.726 Intermediate Similarity NPD2438 Suspended
0.7254 Intermediate Similarity NPD3144 Approved
0.7254 Intermediate Similarity NPD3145 Approved
0.7239 Intermediate Similarity NPD7074 Phase 3
0.7239 Intermediate Similarity NPD7472 Approved
0.723 Intermediate Similarity NPD4162 Approved
0.723 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD37 Approved
0.7222 Intermediate Similarity NPD7228 Approved
0.7222 Intermediate Similarity NPD3818 Discontinued
0.7222 Intermediate Similarity NPD1933 Approved
0.7213 Intermediate Similarity NPD9296 Approved
0.7213 Intermediate Similarity NPD2933 Approved
0.7213 Intermediate Similarity NPD2934 Approved
0.7206 Intermediate Similarity NPD5846 Approved
0.7206 Intermediate Similarity NPD1778 Approved
0.7206 Intermediate Similarity NPD6516 Phase 2
0.7205 Intermediate Similarity NPD6166 Phase 2
0.7205 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD1241 Discontinued
0.7197 Intermediate Similarity NPD4965 Approved
0.7197 Intermediate Similarity NPD4967 Phase 2
0.7197 Intermediate Similarity NPD4966 Approved
0.7195 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7192 Intermediate Similarity NPD2799 Discontinued
0.719 Intermediate Similarity NPD3686 Approved
0.719 Intermediate Similarity NPD3687 Approved
0.7188 Intermediate Similarity NPD6232 Discontinued
0.7185 Intermediate Similarity NPD9545 Approved
0.7183 Intermediate Similarity NPD5163 Phase 2
0.7179 Intermediate Similarity NPD7819 Suspended
0.7179 Intermediate Similarity NPD1465 Phase 2
0.7179 Intermediate Similarity NPD5563 Clinical (unspecified phase)
0.7174 Intermediate Similarity NPD1608 Approved
0.7172 Intermediate Similarity NPD2653 Approved
0.7163 Intermediate Similarity NPD2861 Phase 2
0.7162 Intermediate Similarity NPD4534 Discontinued
0.7161 Intermediate Similarity NPD6873 Phase 2
0.716 Intermediate Similarity NPD7473 Discontinued
0.7154 Intermediate Similarity NPD2860 Approved
0.7154 Intermediate Similarity NPD2859 Approved
0.7153 Intermediate Similarity NPD825 Approved
0.7153 Intermediate Similarity NPD826 Approved
0.7153 Intermediate Similarity NPD2979 Phase 3
0.7152 Intermediate Similarity NPD1511 Approved
0.7152 Intermediate Similarity NPD6799 Approved
0.7143 Intermediate Similarity NPD7458 Discontinued
0.7143 Intermediate Similarity NPD3111 Phase 1
0.7143 Intermediate Similarity NPD1203 Approved
0.7143 Intermediate Similarity NPD3866 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD3268 Approved
0.7133 Intermediate Similarity NPD5110 Phase 2
0.7133 Intermediate Similarity NPD5109 Approved
0.7133 Intermediate Similarity NPD5111 Phase 2
0.7133 Intermediate Similarity NPD5718 Phase 2
0.7132 Intermediate Similarity NPD290 Approved
0.7125 Intermediate Similarity NPD7199 Phase 2
0.7122 Intermediate Similarity NPD6582 Phase 2
0.7122 Intermediate Similarity NPD6583 Phase 3
0.7122 Intermediate Similarity NPD4359 Approved
0.712 Intermediate Similarity NPD3020 Approved
0.7114 Intermediate Similarity NPD4236 Phase 3
0.7114 Intermediate Similarity NPD4237 Approved
0.7113 Intermediate Similarity NPD4908 Phase 1
0.7109 Intermediate Similarity NPD9697 Approved
0.7108 Intermediate Similarity NPD7808 Phase 3
0.7108 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD3536 Discontinued
0.7101 Intermediate Similarity NPD1281 Approved
0.7086 Intermediate Similarity NPD7440 Discontinued
0.7073 Intermediate Similarity NPD5844 Phase 1
0.7071 Intermediate Similarity NPD8651 Approved
0.7071 Intermediate Similarity NPD3225 Approved
0.7071 Intermediate Similarity NPD2922 Phase 1
0.707 Intermediate Similarity NPD2977 Approved
0.707 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD2978 Approved
0.707 Intermediate Similarity NPD1006 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD6331 Phase 2
0.7059 Intermediate Similarity NPD6273 Approved
0.7059 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1512 Approved
0.7059 Intermediate Similarity NPD1548 Phase 1
0.7048 Intermediate Similarity NPD7251 Discontinued
0.7047 Intermediate Similarity NPD5958 Discontinued
0.7042 Intermediate Similarity NPD5736 Approved
0.7037 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7023 Intermediate Similarity NPD5451 Approved
0.7021 Intermediate Similarity NPD987 Approved
0.702 Intermediate Similarity NPD5241 Discontinued
0.702 Intermediate Similarity NPD2354 Approved
0.7019 Intermediate Similarity NPD2821 Approved
0.7014 Intermediate Similarity NPD3764 Approved
0.7014 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7008 Intermediate Similarity NPD291 Approved
0.7007 Intermediate Similarity NPD1651 Approved
0.7007 Intermediate Similarity NPD6896 Approved
0.7007 Intermediate Similarity NPD6895 Approved
0.7 Intermediate Similarity NPD6674 Discontinued
0.7 Intermediate Similarity NPD1652 Phase 2
0.6993 Remote Similarity NPD4123 Phase 3
0.6993 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6993 Remote Similarity NPD4739 Approved
0.6993 Remote Similarity NPD2614 Approved
0.6992 Remote Similarity NPD821 Approved
0.6988 Remote Similarity NPD6797 Phase 2
0.6987 Remote Similarity NPD4380 Phase 2
0.6987 Remote Similarity NPD7028 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data